Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). whether ablation is mandatory or pointless in patients who have HF).

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

DAIC

DECEMBER 27, 2023

The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. Gery Tomassoni , Director of Electrophysiology at Baptist Health Lexington.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

American College of Cardiology

APRIL 24, 2024

Brian Olshansky and John Mandrola currently featured presents a conundrum within the fields of electrophysiology and geriatric cardiology. The CON portion of the PRO/CON debate between Drs.

Atrial Fibrillation 46

Atrial Fibrillation Heart Failure Electrophysiology Ablation 46

Journal of Cardiovascular Electrophysiology

MARCH 3, 2025

ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). Secondary endpoints included all-cause mortality and heart failure (HF)-related hospitalizations. vs. 39.4%, p =0.036).

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

American College of Cardiology

APRIL 24, 2024

He also has New York Heart Association (NYHA) class II heart failure with reduced ejection fraction and left ventricular ejection fraction (LVEF) 40%. PT is an 82-year-old man who presents with persistent, mildly symptomatic atrial fibrillation (AF) of approximately 4-5 months' duration.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Ablation 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Heart failure (HF) with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are associated with high morbidity and mortality. Recently, sinus rhythm (SR) maintenance (SRM) after catheter ablation (CA) of AF (AFCA) in HFpEF has shown to reduce adverse events as compared to medical treatment.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

DAIC

MAY 21, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

HeartRhythm

SEPTEMBER 8, 2023

Atrial fibrillation (AF) stands as the most prevalent cardiovascular disease, posing significant risks of stroke, heart failure (HF), and other complications that contribute to morbidity and mortality.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Cardiovascular Disease 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2023

Abstract Introduction Influence of early atrial fibrillation (AF) ablation, particularly cryoballoon ablation (CBA), on clinical outcome during long-term follow-up has not been clarified. Methods The study included 2605 patients from Korean CBA registry data with follow-up >12 months after de novo CBA. vs. 31.7%, p  = 0.043).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 25, 2024

ABSTRACT Introduction Pulmonary vein isolation (PVI) by cryoballoon ablation (CBA) is considered an effective primary strategy for early persistent atrial fibrillation (AF). However, data regarding CBA for long-standing persistent AF (PeAF) are limited. We evaluated the efficacy and safety of CBA for long-standing PeAF compared to PeAF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 19, 2025

The characterization of the cardiac autonomic nervous system has resulted in a new understanding and appreciation of neurocardiology, leading to potential novel neuromodulation therapies in clinical cardiology and cardiac electrophysiology. Patients with heart failure may be improved clinically by potentiating parasympathetic tone.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Angina Ablation 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2023

Abstract Left ventricular assist device (LVAD) implantation is an established treatment for patients with advanced heart failure refractory to medical therapy. LVAD patients presenting VAs refractory to antiarrhythmic therapy and catheter ablation procedures are not rare.

Arrhythmia 75

Arrhythmia Heart Failure Ablation Outcomes 75

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of Cardiovascular Electrophysiology

JANUARY 9, 2025

Effective management strategies include medical therapy for rate and rhythm control, catheter ablation (CA), and goal-directed medical therapy. It is unclear what impact SGLT2i use may have on AF recurrence following CA.

Atrial Fibrillation 40

Atrial Fibrillation Diabetes Ablation Hospital 40

DAIC

DECEMBER 8, 2023

If untreated, AFib can lead to or exacerbate heart failure, and it significantly increases a person’s risk of stroke. Catheter ablation was given the highest Class 1 treatment recommendation for appropriately selected patients, including those with heart failure with reduced ejection fraction.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

All About Cardiovascular System and Disorders

MARCH 30, 2024

Electrophysiological study will show that, and this pathway can be ablated. Ebstein’s anomaly may present with a murmur for evaluation in the pediatric age group or in adults with arrhythmias or heart failure with cyanosis and exercise intolerance.

Tricuspid 52

Tricuspid Arrhythmia Congenital Heart Disease Electrophysiology 52

Vector Remote

MARCH 9, 2023

All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heart failure, and hypertension requires the ability to monitor a heart’s condition. With The Vector Patient Care Platform™ , patient connectivity and data management for rhythm, heart failure, and hypertension is simplified.

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

Journal of Cardiovascular Electrophysiology

JANUARY 30, 2024

Abstract Introduction In hypertrophic cardiomyopathy (HCM), atrial fibrillation (AF) has historically been regarded to have a deleterious impact on clinical course, strongly associated with progressive heart failure (HF) symptoms. Therefore, we evaluated the impact of AF on QoL utilizing patient reported outcome measures (PROMs).

Quality of Life 40

Quality of Life Atrial Fibrillation Cardiomyopathy Heart Failure 40

DAIC

MARCH 27, 2025

1,2 People living with AFib face an increased risk of stroke, heart failure and death, and many rely on cardiac ablation to treat the condition effectively. of veins during ablation procedures with far fewer energy applications than on-market competitive PFA systems. Procedural flexibility.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

DECEMBER 14, 2023

Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability. The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

APRIL 9, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

Journal of Cardiovascular Electrophysiology

NOVEMBER 26, 2024

ABSTRACT Introduction Atrial fibrillation (AF) can cause or aggravate heart failure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent AF ablation performed during hospitalization for acute HF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Hospital 40

Journal of Cardiovascular Electrophysiology

OCTOBER 21, 2024

Abstract Introduction Catheter ablation for atrial fibrillation (AF) reduces heart failure (HF) hospitalization in patients with HF with preserved ejection fraction (HFpEF). However, the long-term outcomes and subclinical HF after nonparoxysmal AF ablation in HFpEF patients have not been fully evaluated.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

AF-CHF trial in those with AF and congestive heart failure also failed to show any advantage for the rhythm control strategy [3]. Nearly two thirds in the rhythm control strategy were on amiodarone and only 14 had catheter ablation. In the rhythm control arm, either drug therapy or catheter ablation could be used.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

DAIC

JUNE 19, 2024

Higher up the cardiovascular patient pathway, AI-based ECG algorithms that create 2D and 3D maps of the heart (Vektor Medical) are being used to shorten ablation procedure times, resulting in reduced procedure costs and patient risks.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Regardless of the catheter ablation (CA) for atrial fibrillation (AF) strategy, the role of early recurrences during the blanking period (BP) is still unclear. Male sex, chronic heart failure, persistent AF, and recurrences during the BP were found to be associated with long-term ATA recurrences.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2023

This study included 1188 patients who underwent initial ablation for atrial fibrillation (AF). Methods This observational study included 1118 consecutive patients undergoing initial ablation for AF. 13.4); and heart failure for volumetric (1.71, 1.51–2.53) 3.25) and combined remodeling (2.57, 1.88–3.49);

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Outcomes 40

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Introduction The safety and efficacy of paroxysmal atrial fibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. Central Illustration. Image is courtesy of Biosense Webster, Inc., All rights reserved.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Atrial Flutter Ablation 40

Cardiometabolic Health Congress

DECEMBER 7, 2023

Furthermore, it includes the latest recommendations which specifically address AF and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, AF catheter or surgical ablation, and risk factor modification and AF prevention. As such, the Class of Recommendation for catheter ablation has been upgraded.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Scott Rankin Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures The Annals of Thoracic Surgery June 2018 A. Chris Malaisrie Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting The Journal of Thoracic and Cardiovascular Surgery June 2018 J.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Scott Rankin 1 Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures The Annals of Thoracic Surgery June 2018 A. Chris Malaisrie Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting The Journal of Thoracic and Cardiovascular Surgery June 2018 J.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Journal of the American Heart Association

MARCH 21, 2025

Journal of the American Heart Association, Ahead of Print. BackgroundLowvoltage areas in the left atrium predict atrial fibrillation recurrence after catheter ablation and are associated with adverse outcomes like death, heart failure, and stroke. Blood samples were collected during ablation to measure VIP using an ELISA.

Atrial Fibrillation 45

Atrial Fibrillation Biomarkers Ablation Electrophysiology 45

Journal of Cardiovascular Electrophysiology

FEBRUARY 21, 2025

ABSTRACT Background Exercise Oscillatory Ventilation (EOV) and a steep ventilatory efficiency (VE/VCO2) slope are features of ventilatory inefficiency on cardiopulmonary exercise testing (CPET), both associated with poor prognosis in patients with heart failure (HF).

Atrial Fibrillation 40

Atrial Fibrillation Cardiomyopathy Ablation Exercise 40

Journal of Cardiovascular Electrophysiology

JANUARY 7, 2025

ABSTRACT Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.

Atrial Flutter 45

Atrial Flutter Atrial Fibrillation Quality of Life Ablation 45